Ifp Advisors, Inc Verastem, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change
Q3 2021 Oct 06, 2021	SELL	$2.54 - $4.07 $0 - $0	0 Closed
Q2 2021 Jul 13, 2021	BUY	$2.57 - $4.85 $0 - $0	0 New
Q1 2021 Apr 30, 2021	BUY	$1.9 - $2.82 $0 - $0	0 New
Q4 2020 Jan 25, 2021	BUY	$1.15 - $2.4 $0 - $0	0 New
Q3 2020 Oct 29, 2020	BUY	$1.11 - $1.68 $0 - $0	0 New
Q2 2020 Aug 05, 2020	BUY	$1.69 - $4.2 $0 - $0	0 New

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.2B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.